As it turns out, a healthy gut is something people will pay a lot of money for. The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015 and is expected to grow to $63.8 billion in 2021.1 There has been a rise in reported cases of issues such as Celiac’s disesase, irritable bowel, inflammatory bowel disease (IBD) and Crohn’s, which necessitates the need for better and more varied medication.

Ensuring better-managed stocks of high-quality vaccines is the key to addressing large-scale outbreaks. Image Source: Flickr User CDC Global Health Over the last couple of years, there have been massive outbreaks of nightmarish illnesses such as Zika virus, Ebola, Yellow Fever and the resurgence of both measles and mumps. Many […]

As concerns about the drug manufacturing process grow, pharmaceutical companies must adopt digital solutions that reduce quality variability. Image source: Flickr CC user Michael Chen Last year, the FDA proposed standards for quality metrics and followed that up with guidelines covering data integrity and cGMP compliance. The latter, in particular, […]

While many pharmaceutical firms have devoted significant resources to exploring the innovative realm of biologics, small molecule drug discovery remains a priority for multiple types of disease therapy. For illnesses like cancer, which have several subtypes and underlying biological mechanisms, a wide variety of treatment options is necessary to help […]

Today’s health-conscious consumer pays more attention to the ingredients used in everyday consumer packaged goods. Many people believe that all-natural materials are better for overall health and they seek out personal care products free from synthetic chemicals as a result. CPG companies should be aware of this trend and adapt their formulations to capitalize on a growing market.